Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways.
Ontology highlight
ABSTRACT: A convincing deal of evidence supports the fact that severe psoriasis is associated with cardiovascular diseases. However, the precise underlying mechanisms linking psoriasis and cardiovascular diseases are not well defined. Psoriasis shares common pathophysiologic mechanisms with atherosclerosis and cardiovascular (CV) risk factors. In particular, polymorphism in the IL-23R and IL-23 genes, as well as other genes involved in lipid and fatty-acid metabolism, renin-angiotensin system and endothelial function, have been described in patients with psoriasis and with cardiovascular risk factors. Moreover, systemic inflammation in patients with psoriasis, including elevated serum proinflammatory cytokines (e.g., TNF-α, IL-17, and IL-23) may contribute to an increased risk of atherosclerosis, hy
SUBMITTER: Piaserico S
PROVIDER: S-EPMC9409274 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA